Higher Post-Operative Serum Vitamin D Level is Associated with Better Survival Outcome in Colorectal Cancer Patients

References

• Garland CF, and Garland FC: Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 35, 217–220, 2006.
   PubMed Web of Science ®Google Scholar
• Holick MF: Vitamin D deficiency. N Engl J Med 357, 266–281, 2007.
   PubMed Web of Science ®Google Scholar
• Autier P, Boniol M, Pizot C, and Mullie P: Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2, 76–89, 2014.
   PubMed Web of Science ®Google Scholar
• Feldman D, Krishnan AV, Swami S, Giovannucci E, and Feldman BJ: The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer 14, 342–357, 2014.
   PubMed Web of Science ®Google Scholar
• Gocek E, and Studzinski GP: Vitamin D and differentiation in cancer. Crit Rev Clin Lab Sci 46, 190–209, 2009.
   PubMed Web of Science ®Google Scholar
• van Harten-Gerritsen AS, Balvers MG, Witkamp RF, Kampman E, and van Duijnhoven FJ: Vitamin D, inflammation, and colorectal cancer progression: a review of mechanistic studies and future directions for epidemiological studies. Cancer Epidemiol Biomarkers Prev 24, 1820–1828, 2015.
   PubMed Web of Science ®Google Scholar
• Chung I, Han G, Seshadri M, Gillard BM, Yu WD, et al. Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo. Cancer Res 69, 967–975, 2009.
   PubMed Web of Science ®Google Scholar
• Dou R, Ng K, Giovannucci EL, Manson JE, Qian ZR, et al.: Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence. Br J Nutr 115, 1643–1660, 2016.
   PubMed Web of Science ®Google Scholar
• Jacobs ET, Kohler LN, Kunihiro AG, and Jurutka PW: Vitamin D and colorectal, breast, and prostate cancers: a review of the epidemiological evidence. J Cancer 7, 232–240, 2016.
   PubMed Web of Science ®Google Scholar
• Vaughan-Shaw PG, O'Sullivan F, Farrington SM, Theodoratou E, Campbell H, et al. The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis. Br J Cancer 116, 1092–1110, 2017.
   PubMed Web of Science ®Google Scholar
• Newmark HL, Yang K, Kurihara N, Fan K, Augenlicht LH, et al.: Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis 30, 88–92, 2009.
   PubMed Web of Science ®Google Scholar
• Theodoratou E, Tzoulaki I, Zgaga L, and Ioannidis JP: Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 348, g2035, 2014.
   PubMed Web of Science ®Google Scholar
• Maalmi H, Ordonez-Mena JM, Schottker B, and Brenner H: Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies. Eur J Cancer 50, 1510–1521, 2014.
   PubMed Web of Science ®Google Scholar
• Zgaga L, Theodoratou E, Farrington SM, Din FV, Ooi LY, et al. Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer. J Clin Oncol 32, 2430–2439, 2014.
   PubMed Web of Science ®Google Scholar
• Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 1, CD007470, 2014.
   PubMed Web of Science ®Google Scholar
• Keum N, and Giovannucci E: Vitamin D supplements and cancer incidence and mortality: a meta-analysis. Br J Cancer 111, 976–980, 2014.
   PubMed Web of Science ®Google Scholar
• Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 348, g1903, 2014.
   PubMed Web of Science ®Google Scholar
• Yang L, Chen H, Zhao M, and Peng P: Prognostic value of circulating vitamin D binding protein, total, free and bioavailable 25-hydroxy vitamin D in patients with colorectal cancer. Oncotarget 8, 40214–40221, 2017.
   PubMedGoogle Scholar
• Maalmi H, Walter V, Jansen L, Chang-Claude J, Owen RW, et al. Relationship of very low serum 25-hydroxyvitamin D3 levels with long-term survival in a large cohort of colorectal cancer patients from Germany. Eur J Epidemiol 32, 961–971, 2017.
   PubMed Web of Science ®Google Scholar
• Fedirko V, Riboli E, Tjonneland A, Ferrari P, Olsen A, et al. Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European populations. Cancer Epidemiol Biomarkers Prev 21, 582–593, 2012.
   PubMed Web of Science ®Google Scholar
• Reid D, Toole BJ, Knox S, Talwar D, Harten J, et al. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr 93, 1006–1011, 2011.
   PubMed Web of Science ®Google Scholar
• Santini D, Galluzzo S, Vincenzi B, Zoccoli A, Ferraro E, et al. Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients. Ann Oncol 21, 185–186, 2010.
   PubMed Web of Science ®Google Scholar
• Gama R, Waldron JL, Ashby HL, Cornes MP, Bechervaise J, et al. Hypovitaminosis D and disease: consequence rather than cause? BMJ 345, e5706, 2012.
   PubMed Web of Science ®Google Scholar
• Louw JA, Werbeck A, Louw ME, Kotze TJ, Cooper R, et al.: Blood vitamin concentrations during the acute-phase response. Crit Care Med 20, 934–941, 1992.
   PubMed Web of Science ®Google Scholar
• Vayrynen JP, Mutt SJ, Herzig KH, Vayrynen SA, Kantola T, et al. Decreased preoperative serum 25-hydroxyvitamin D levels in colorectal cancer are associated with systemic inflammation and serrated morphology. Sci Rep 6, 36519, 2016.
   PubMed Web of Science ®Google Scholar
• Freedman DM, Looker AC, Abnet CC, Linet MS, and Graubard BI: Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988–2006). Cancer Res 70, 8587–8597, 2010.
   PubMed Web of Science ®Google Scholar
• Ross AC, Taylor CL, Yaktine AL, and Del Valle HB, editors. Dietary reference intakes for calcium and vitamin D. The National Academies Collection: Reports funded by National Institutes of Health, Washington, DC, 2011.
   Google Scholar
• Facciorusso A, Del Prete V, Muscatiello N, Crucinio N, and Barone M: Prognostic role of 25-hydroxyvitamin D in patients with liver metastases from colorectal cancer treated with radiofrequency ablation. J Gastroenterol Hepatol 31, 1483–1488, 2016.
   PubMed Web of Science ®Google Scholar
• Mezawa H, Sugiura T, Watanabe M, Norizoe C, Takahashi D, et al. Serum vitamin D levels and survival of patients with colorectal cancer: post-hoc analysis of a prospective cohort study. BMC Cancer 10, 347, 2010.
   PubMed Web of Science ®Google Scholar
• Ng K, Meyerhardt JA, Wu K, Feskanich D, Hollis BW, et al. Circulating 25-hydroxy vitamin D levels and survival in patients with colorectal cancer. J Clin Oncol 26, 2984–2991, 2008.
   PubMed Web of Science ®Google Scholar
• Roy S, Sherman A, Monari-Sparks MJ, Schweiker O, and Hunter K: Correction of low vitamin D improves fatigue: effect of correction of low vitamin D in fatigue study (EViDiF study). N Am J Med Sci 6, 396–402, 2014.
   PubMedGoogle Scholar
• Wesa KM, Segal NH, Cronin AM, Sjoberg DD, Jacobs GN, et al. Serum 25-hydroxy vitamin D and survival in advanced colorectal cancer: a retrospective analysis. Nutr Cancer 67, 424–430, 2015.
   PubMed Web of Science ®Google Scholar
• Ng K, Sargent DJ, Goldberg RM, Meyerhardt JA, Green EM, et al. Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. J Clin Oncol 29, 1599–1606, 2011.
   PubMed Web of Science ®Google Scholar
• Saneei P, Salehi-Abargouei A, and Esmaillzadeh A: Serum 25-hydroxy vitamin D levels in relation to body mass index: a systematic review and meta-analysis. Obes Rev 14, 393–404, 2013.
   PubMed Web of Science ®Google Scholar
• Conway FJ, and McMillan DC: Plasma vitamin D concentration and survival in colorectal cancer: potential confounding by the systemic inflammatory response. J Clin Oncol 33, 224, 2015.
   PubMed Web of Science ®Google Scholar
• Fang S, Sui D, Wang Y, Liu H, Chiang YJ, et al. Association of Vitamin D levels with outcome in patients with melanoma after adjustment for C-reactive protein. J Clin Oncol 34, 1741–1747, 2016.
   PubMed Web of Science ®Google Scholar
• Song M, Wu K, Chan AT, Fuchs CS, and Giovannucci EL: Plasma 25-hydroxyvitamin D and risk of colorectal cancer after adjusting for inflammatory markers. Cancer Epidemiol Biomarkers Prev 23, 2175–2180, 2014.
   PubMed Web of Science ®Google Scholar